Vivo Ventures V, LLC's Net Worth

$2.16 Million

Estimate Recalculated Dec 3, 2025 08:04PM EST

Who is Vivo Ventures V, LLC

Vivo Ventures V, LLC has an estimated net worth of $2.16 Million. This is based on reported shares across multiple companies, which include Sagent Holding Co., Capnia, Inc., MEI Pharma, Inc., and Biodel Inc.

SEC CIK

Vivo Ventures V, LLC's CIK is 0001399028

Past Insider Trading and Trends

2017 was Vivo Ventures V, LLC's most active year for acquiring shares with 3 total transactions. Vivo Ventures V, LLC's most active month to acquire stocks was the month of March. 2017 saw Vivo Ventures V, LLC paying a total of $26,249.32 for 45,059 shares, this is the most they've acquired in one year.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sagent Pharmaceuticals, Inc.

Investor

Updated Sep 01, 2016


Form 4	-100.00%	-3.01M	$21.75	-$65.55M	Sep 01, 2016	—	Disposition	—	Aug 29
Form 4	-0.07%	-2.00K	$13.55	-$27.17K	Apr 25, 2016	3.01M	Sale	—	Apr 21
Form 4	-5.67%	-603.18K	$16.21	-$9.48M	Nov 04, 2015	10.03M	Sale	—	Nov 02 - Nov 04
Form 4	-12.96%	-539.02K	$21.25	-$11.45M	Sep 17, 2013	3.62M	Sale	—	Sep 16
Form 3	—	—	—	—	Apr 19, 2011	4.16M	—	—	—

Showing 5 results

SOLENO THERAPEUTICS INC

Investor

Updated Dec 03, 2019

View Quote Details


Form 4	-0.93%	-34.03K	$1.62	-$55.13K	Dec 03, 2019	3.63M	Sale	—	Dec 02
Form 4	-0.49%	-18.07K	$1.55	-$27.95K	Nov 27, 2019	3.67M	Sale	—	Nov 26 - Nov 27
Form 4	-1.65%	-61.67K	$1.55	-$95.74K	Nov 25, 2019	3.69M	Sale	—	Nov 21 - Nov 25
Form 4	-1.10%	-41.63K	$1.55	-$64.52K	Nov 20, 2019	3.75M	Sale	—	Nov 18 - Nov 20
Form 4	-2.50%	-97.02K	$1.55	-$150.39K	Nov 15, 2019	3.79M	Sale	—	Nov 13 - Nov 15
Form 4	-0.23%	-8.76K	$1.55	-$13.58K	Nov 07, 2019	3.89M	Sale	—	Nov 05
Form 4	-7.91%	-334.42K	$1.57	-$524.79K	Nov 04, 2019	3.89M	Sale	—	Oct 31 - Nov 04
Form 4	-0.72%	-30.55K	$1.59	-$48.51K	Oct 28, 2019	4.23M	Sale	—	Oct 24 - Oct 28
Form 4	4.12%	326.15K	$3.40	$1.11M	Aug 09, 2018	8.25M	Acquisition	—	Mar 07 - May 14
Form 4	66.31%	1.89M	$1.84	$2.00M	Dec 19, 2017	4.74M	Purchase	—	Dec 15
Form 4	59.60%	16.83K	$0.52	$8.75K	Oct 04, 2017	14.29M	Grant	—	Oct 02
Form 4	103.28%	14.34K	$0.61	$8.75K	Jul 17, 2017	14.27M	Grant	—	Jul 06
Form 4	—	13.89K	$0.63	$8.75K	Apr 14, 2017	14.26M	Grant	—	Apr 07
Form 4	103.35%	7.24M	$0.96	—	Mar 09, 2017	14.24M	Purchase	—	Mar 07
Form 4	1.69%	116.22K	—	—	Feb 09, 2016	7.00M	Acquisition	—	Feb 08
Form 4	3.83%	253.79K	—	—	Jan 12, 2016	6.89M	Acquisition	—	Jan 08
Form 4	23.21%	1.25M	—	—	Nov 23, 2015	6.63M	Acquisition	—	Nov 19
Form 4	17.48%	801.25K	—	—	Aug 18, 2015	5.38M	Acquisition	—	Aug 14
Form 4	14.96%	596.46K	—	—	Aug 14, 2015	4.58M	Acquisition	—	Aug 12
Form 4	-131.30%	-6.13M	—	—	Nov 20, 2014	24.93M	Sale	—	Nov 18
Form 3	—	—	—	—	Nov 12, 2014	31.76K	—	—	—

Showing 21 results

MEI Pharma, Inc.

Investor

Updated Nov 09, 2015

View Quote Details


Form 4	-10.99%	-22.69K	$1.84	-$41.85K	Nov 09, 2015	183.77K	Sale	—	Nov 05 - Nov 09
Form 4	32.67%	50.85K	$3.12	$82.51K	Mar 26, 2015	206.46K	Options	—	Mar 24
Form 4	-8.82%	-17.41K	$8.21	-$142.97K	Oct 29, 2013	180.02K	Sale	—	Oct 25 - Oct 29
Form 4	-14.62%	-33.79K	$10.16	-$343.50K	Oct 03, 2013	197.42K	Sale	—	Oct 01 - Oct 02
Form 4	-0.18%	-426.00	$7.58	-$3.23K	Jul 02, 2013	231.22K	Sale	—	Jun 28
Form 4	-5.59%	-13.73K	$7.80	-$107.07K	Jun 13, 2013	231.64K	Sale	—	Jun 11
Form 4	-0.41%	-1.01K	$9.07	-$9.17K	May 20, 2013	245.37K	Sale	—	May 16
Form 3	—	—	—	—	Dec 21, 2012	270.78K	—	—	—

Showing 8 results

Biodel Inc

Investor

Updated May 18, 2007


Form 4	—	—	—	—	May 18, 2007	1.69M	Options	—	May 16
Form 3	—	—	—	—	May 10, 2007	606.70K	—	—	—

Showing 2 results